Navigation Links
CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors
Date:3/3/2009

BURLINGTON, Mass., Mar. 3 /PRNewswire/ -- CorNova, Inc. today announced the addition of Andrew T. Jay, D.M.D., to its board of directors. The addition increases board membership to 4.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO )

Dr. Jay, 46, is the managing partner of the Medical Solutions Fund of Siemens Venture Capital GmbH, the venture organization for Siemens AG. Prior to joining Siemens Venture Capital, he was an Institutional Investor-ranked medical technology analyst with both Alex. Brown and Wachovia Securities, where his coverage included cardiovascular device companies. Dr. Jay received his D.M.D. from the University of Pennsylvania and his M.B.A. from the Kellogg School at Northwestern. He earned his B.S. from Rensselaer Polytechnic Institute.

"Adding such an accomplished and experienced venture investor and medical technology analyst to our board is an important step in the development of CorNova," said S. Eric Ryan, M.D., CorNova's chief executive officer. "His advice will be invaluable as our company advances our FiberHalo(TM) angioplasty catheter toward commercialization, and we move forward to CE-Mark approval for our Valecor Platinum(TM) Coronary Stent System."

"CorNova's FiberHalo catheter and Valecor Platinum Coronary Stent System address two separate billion dollar market opportunities with approaches that could sell well on their own or shift market share significantly in the hands of a major player in the cardiovascular space," said Dr. Jay. He is taking this role independent of his activity at Siemens Venture Capital.

About CorNova

CorNova is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better pa
'/>"/>

SOURCE CorNova, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Marketing Technology Solutions Announces Strong 2008 Growth and Web Site Enhancements for QualityHealth.com
2. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
3. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
4. Osteotech Announces Fourth Quarter and Full Year 2008 Earnings Release and Conference Call; Company to Release Financial Results on Wednesday, March 4, 2009 and Host Call on Thursday, March 5, 2009
5. WellPoint Announces Appearances at Upcoming Conferences
6. Align Technology Announces International Availability of Invisalign Teen(TM)
7. MHA Announces: Launch of New Website
8. National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs
9. Lilly Announces Leadership Changes
10. Availity Announces Support of Project SwipeIT
11. The Vitality Group Announces Expansion to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...new study appearing in the February 22 issue of th...d no significant differences in the effectiveness ...s or paclitaxel. Drug-releasing stents are known t...or the outcome of procedures like angioplasty, whe...
...rthwestern Memorial Hospital along with Northweste...cting a Phase II clinical trial to determine if av... drug also known as bevacizumab is an anti-angioge...radiation therapy and chemotherapy can reduce loca...
...e ripple effect caused by the bird flu threat has ...vable 60 percent down in the Indian capital. One c...eing sold for just Rs. 12 per kg. // Only th...ified was available for a mere Rs.12 per kg. ...
...e first ever-cervical cancer vaccine, Gardasil is ...ting females between 9 and 24 years of age. // Soo...s to prevent them from infecting their sexual part...r prevention. Most cases of cervical cancer can be...
...ndon: European Union has a huge health problem of...er one health ailment in the Union, that costed th...2003, according to a study. // Take a look at...e costs, per person. As a consequence, absenteeism...
...e SRY or the sex determination gene, that plays a ...op into a male or female (embryo with SRY gene dev...ce of Parkinson's disease in men. // The SRY prote... University of California. The SRY gene was ...
Other Medicine News:Health News:Avastin under trial to test efficacy for pancreatic tumours! 2Health News:Delhi Sees Sharp Decline In Chicken Prices 2Health News:Delhi Sees Sharp Decline In Chicken Prices 3Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2
(Date:12/4/2009)INDIANAPOLIS, Dec. 4 The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31 2009 and the First Fi 13635 1China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31 2009 and the First Fi 13635 2Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 1Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 2Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 3Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats 54939 1Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats 54939 2
...nse revenue increases more than 100% in third quar...global,leader in scalable behavior change interven...ips and continued to experience rapid growth,throu...introduced,enhancements to its HealthMedia Connect...d innovation., HealthMedia,s health care license ...
...rch Is a Winning Pursuit, WASHINGTON, Dec. 19 Th... President, Foundation for Biomedical,Research:, ...lth deemed "not,worthy of pursuit" in 1980 earned ... the early setback, the Harvard-educated genetics ...ears, Capecchi filed another NIH,grant proposal, t...
Other Medicine Technology:HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 2HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 3Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: